Komori
Share Issuance and Disposal4563AnGes,Inc.Pharmaceuticals

Notice Concerning the Monthly Exercise Status of Stock Acquisition Rights with Exercise Price Adjustment Provisions

For the 46th Series of Stock Acquisition Rights with Exercise Price Adjustment Provisions, rights corresponding to 700,000 shares were exercised during March 2026, reducing the unexercised balance from 869,171 rights to 862,171 rights.

Worth reading
55In focus
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
700000
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Monthly exercise status of stock acquisition rights with an exercise price adjustment clause

発行・処分する株式数

Number of shares delivered during the month: 700,000 shares (700,000 new shares and 0 transferred treasury shares)

Terms of the stock acquisition rights
Exercise price
Exercise price during the month: ¥49.5–¥54.0. Whether an adjustment provision exists and the adjustment floor: Not disclosed
Number of Stock Acquisition Rights
Total number issued: 700,000 rights, equivalent to 0.73% of the total number issued. Unexercised at the end of the preceding month: 869,171 rights; unexercised at the end of the month: 862,171 rights
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Transactions.
Most recent equity financing
25 November 2025: Issuance of the 46th Series of Stock Acquisition Rights with Exercise Price Adjustment Provisions (see the materials released on 7 November 2025 for details)
Details of issuance or disposal
ItemDetails
Type of issuance or disposalMonthly exercise status of stock acquisition rights with an exercise price adjustment clause
Number of shares to be issued or disposed ofNumber of shares delivered during the month: 700,000 shares (700,000 new shares and 0 transferred treasury shares)
Total number of issued shares395,626,550 shares (including 230 treasury shares) → Not disclosed
Exercise priceExercise price during the month: ¥49.5–¥54.0. Whether an adjustment provision exists and the adjustment floor: Not disclosed
Number of Stock Acquisition RightsTotal number issued: 700,000 rights, equivalent to 0.73% of the total number issued. Unexercised at the end of the preceding month: 869,171 rights; unexercised at the end of the month: 862,171 rights
Procedures under the Corporate Code of ConductThe disclosure describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Transactions.
Most recent equity financing25 November 2025: Issuance of the 46th Series of Stock Acquisition Rights with Exercise Price Adjustment Provisions (see the materials released on 7 November 2025 for details)
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To report the monthly exercise status of the 46th Series of Stock Acquisition Rights with Exercise Price Adjustment Provisions for March 2026.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning the Monthly Exercise Status of Stock Acquisition Rights with Exercise Price Adjustment Provisions | AnGes,Inc. (4563) timely disclosure | Komori